Industry reports
Editor highlights

Search inside this page

Free Market Research Guides to Download

Pharmaceutical Analysis & Statistics in Oceania Countries, May 2013 (p6)

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

151-200 of about 500 reports
Incivek (Hepatitis C Virus) - Forecast and Market Analysis to 2022

Incivek (Hepatitis C Virus) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • May 2013
  • by Global Data

Incivek (Hepatitis C Virus) - Forecast and Market Analysis to 2022 Summary Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, United States, Australia, Europe, United Kingdom, China
Xeljanz (Psoriasis) - Forecast and Market Analysis to 2022

Xeljanz (Psoriasis) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • May 2013
  • by Global Data

Xeljanz (Psoriasis) - Forecast and Market Analysis to 2022 Summary Psoriasis is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide (Perera ...

  • Industries : Pathology
  • Countries : Germany, Japan, World, Brazil, Spain, Italy, France, United States, Australia, Europe, United Kingdom, China
Victrelis (Hepatitis C Virus) - Forecast and Market Analysis to 2022

Victrelis (Hepatitis C Virus) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • May 2013
  • by Global Data

Victrelis (Hepatitis C Virus) - Forecast and Market Analysis to 2022 Summary Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The ...

  • Industries : Pathology
  • Countries : World, Brazil, United States, Spain, Italy, France, Germany, Japan, Australia, Europe, United Kingdom, China
Apremilast (Psoriasis) - Forecast and Market Analysis to 2022

Apremilast (Psoriasis) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • May 2013
  • by Global Data

Apremilast (Psoriasis) - Forecast and Market Analysis to 2022 Summary Psoriasis is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide ...

  • Industries : Pathology
  • Countries : Italy, France, World, Brazil, Spain, Germany, Japan, United States, United Kingdom, Europe, Australia, China
Alzumab (Psoriasis) - Forecast and Market Analysis to 2022

Alzumab (Psoriasis) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • May 2013
  • by Global Data

Alzumab (Psoriasis) - Forecast and Market Analysis to 2022 Summary Psoriasis is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide (Perera ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, United States, Australia, Europe, United Kingdom, India, China
Inclusion Body Myositis (IBM) - Pipeline Review, H1 2013

Inclusion Body Myositis (IBM) - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • May 2013
  • by Global Markets Direct

Inclusion Body Myositis (IBM) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Inclusion Body Myositis (IBM) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...

  • Industries : Pathology
  • Countries : New Zealand, World
Pharmaceutical in United States: Hospira, Inc. ? Product Pipeline Review - H2 2011

Pharmaceutical in United States: Hospira, Inc. ? Product Pipeline Review - H2 2011

  • $ 1 500
  • Company report
  • May 2013
  • by Global Markets Direct

- Product Pipeline Review - H2 2011? provides a detailed overview on the Hospira, Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with latest ...

  • Industries : Therapy
  • Countries : United States, India, Australia, World, Japan
Haemophilus Influenzae Type b Infections - Pipeline Review, H1 2013

Haemophilus Influenzae Type b Infections - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • May 2013
  • by Global Markets Direct

Haemophilus Influenzae Type b Infections - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Haemophilus Influenzae Type b Infections - Pipeline Review, H1 2013', provides an overview of the ...

  • Industries : Drug and Medication
  • Countries : World, India, Australia
Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Telesso Technologies Limited (TEO)

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Telesso Technologies Limited (TEO)

  • $ 250
  • Company report
  • May 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pharmaceutical
  • Countries : Australia
NeuroDiscovery Limited (NDL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NeuroDiscovery Limited (NDL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2013
  • by Global Data

Summary NeuroDiscovery Ltd (NeuroDiscovery) is a neuroscience drug development company, based in Australia. The company provides neuroscience services and drug development. Its products include NSL-101 ...

  • Industries : Drug Discovery and Development
  • Countries : Australia
NeuroDiscovery Limited (NDL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NeuroDiscovery Limited (NDL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2013
  • by Global Data

Summary NeuroDiscovery Ltd (NeuroDiscovery) is a neuroscience drug development company, based in Australia. The company provides neuroscience services and drug development. Its products include NSL-101 ...

  • Industries : Drug Discovery and Development
  • Countries : Australia
New Zealand Pharmaceuticals and Healthcare Report Q3 2013

New Zealand Pharmaceuticals and Healthcare Report Q3 2013

  • $ 1 300
  • Industry report
  • May 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Low growth potential in New Zealand's pharmaceutical market will attract risk-averse investors. However, we note that regulatory delays in funding new medicines ...

  • Industries : Drug and Medication
  • Countries : New Zealand
The University of Melbourne - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The University of Melbourne - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2013
  • by Global Data

Summary The University of Melbourne (UM) is an educational service provider. The university provides awareness and management services to the society in the field of research and teaching services. It ...

  • Industries : Pharmaceutical
  • Countries : Australia
Vaccines - Global Markets Package

Vaccines - Global Markets Package

  • $ 24 060
  • Industry report
  • May 2013
  • by Global Research & Data Services

This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different countries around the world. The studies provide essential market ...

  • Industries : Drug and Medication
  • Countries : World, Europe, Asia, South America, Czech Republic, South Korea, Philippines, Africa, Australia, Argentina, United States, United Kingdom, Netherlands, Macedonia, Lithuania, Sri Lanka, Singapore, Kazakhstan, Indonesia, Bangladesh, Azerbaijan, South Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Panama, Mexico, Canada, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Belgium, Austria, Thailand, Pakistan, Nepal, Mongolia, Malaysia, Lebanon, Jordan, Japan, India, China, Georgia, Armenia, Sudan, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt, Kyrgyz Republic (kyrgyzstan), North America, Peru, Oman, Iran
Vaccine Market in Australia

Vaccine Market in Australia

  • $ 652
  • Industry report
  • May 2013
  • by Global Research & Data Services

This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in Australia. The study provides essential market information for decision-makers ...

  • Industries : Drug and Medication
  • Countries : Australia
Monash University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Monash University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2013
  • by Global Data

Summary Monash University (Monash) is an education center. The University offers a wide range of undergraduate programs and various postgraduate coursework programs. Monash offers its undergraduate and ...

  • Industries : Pathology
  • Countries : Australia
EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022

EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • May 2013
  • by Global Data

EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022 Summary Meningococcal disease is caused by Neisseria meningitidis, which is an encapsulated, Gram-negative bacterium that has an ...

  • Industries : Pathology
  • Countries : World, Australia, Brazil, Spain, United States, United Kingdom, Italy, France, Germany
Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer's Disease

Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer's Disease

  • $ 3 500
  • Industry report
  • May 2013
  • by GBI Research

Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer's Disease Summary ...

  • Industries : Pathology
  • Countries : Australia, Japan, United States, India, World, Europe, China
Pain Medication OTC Manufacturing in Australia - Industry Market Research Report

Pain Medication OTC Manufacturing in Australia - Industry Market Research Report

  • $ 890
  • Industry report
  • May 2013
  • by Ibisworld

Growth pains: Competition from manufacturers abroad hampers industry revenue Pain Medication OTC Manufacturing in Australia Companies in this industry research and develop medicines with pain-relieving, ...

  • Industries : Drug and Medication
  • Countries : Australia
Australia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Australia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Given the country’s increasingly ageing population and the consequential rise in noncommunicable diseases, Australia is a highly attractive place for multinational ...

  • Industries : Drug and Medication
  • Countries : Australia
Sigma Pharmaceuticals Limited (Symbol:SIP) SWOT Analysis, Strategy, Revenues and Profits

Sigma Pharmaceuticals Limited (Symbol:SIP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2013
  • by Global Data

Sigma Pharmaceuticals Limited (Sigma) is an Australian pharmaceutical company. Sigma is principally engaged in marketing, wholesale and retail distribution of pharmaceutical products through the pharmacy ...

  • Industries : Pharmaceutical
  • Countries : Australia
Emerging Drug Delivery Technologies, Profiles of Start-ups and Early-Stage Companies

Emerging Drug Delivery Technologies, Profiles of Start-ups and Early-Stage Companies

  • $ 1 995
  • Industry report
  • May 2013
  • by MCD Group

MCD Group continuously researches and monitors emerging drug delivery technologies and has compiled this report to profile some of the innovative developments at younger, emerging companies. The report ...

  • Industries : Drug Delivery Technology
  • Countries : Australia, Canada
Sarepta Therapeutics, Inc. - Product Pipeline Review - 2013

Sarepta Therapeutics, Inc. - Product Pipeline Review - 2013

  • $ 1 500
  • Company report
  • April 2013
  • by Global Markets Direct

Sarepta Therapeutics, Inc. - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, ?Sarepta Therapeutics, Inc. - Product Pipeline Review - 2013? provides data on the Sarepta ...

  • Industries : Therapy
  • Countries : World, Australia
Mylan Inc. : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report

Mylan Inc. : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • April 2013
  • by ICD Research

Synopsis ICD Research's "Mylan Inc. : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile ...

  • Industries : Drug Delivery Technology
  • Countries : United States, New Zealand, Australia, Canada, Japan, India, World
Pathology in United States: Diphtheria - Pipeline Review, H1 2012

Pathology in United States: Diphtheria - Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Diphtheria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Drug and Medication
  • Countries : Japan, World, United States, Australia
Unilife Corporation (UNIS) - Product Pipeline Analysis, 2013 Update

Unilife Corporation (UNIS) - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • April 2013
  • by Global Data

Summary Unilife Corporation (Unilife) is a developer and commercial supplier of injectable drug delivery systems. It carries out the design, development, manufacture and distribution of safety engineered ...

  • Industries : Drug Delivery Technology
  • Countries : United States, Australia
STADA Arzneimittel AG (Symbol:SAZ) SWOT Analysis, Strategy, Revenues and Profits

STADA Arzneimittel AG (Symbol:SAZ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • April 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : Germany, Belgium, Australia
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants

Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants

  • $ 3 500
  • Industry report
  • April 2013
  • by GBI Research

Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants ...

  • Industries : Drug and Medication
  • Countries : Philippines, Singapore, New Zealand, Australia, Malaysia, Taiwan, Japan, China, Asia, India, Oceania, World
MarketVIEW: Typhoid travel vaccines

MarketVIEW: Typhoid travel vaccines

  • $ 4 495
  • Industry report
  • April 2013
  • by VacZine Analytics Group Of Assay Advantage Ltd

Typhoid fever is caused by Salmonella typhi bacteria that are transmitted through contaminated food and drink in conditions of poor sanitation. Without prompt treatment with antibiotics typhoid fever can ...

  • Industries : Drug and Medication
  • Countries : World, Australia, Europe, United States, Canada, Spain, Italy, France, Germany, United Kingdom
MarketVIEW: Cholesterol vaccines

MarketVIEW: Cholesterol vaccines

  • $ 8 995
  • Industry report
  • April 2013
  • by VacZine Analytics Group Of Assay Advantage Ltd

Cardiovascular disease(s) (CVD) are prominent within the 10 leading causes of death in high-income countries. The most common manifestations of CVD are coronary heart disease (CHD), ischaemic stroke, and ...

  • Industries : Drug and Medication
  • Countries : Australia, Europe, United States, Canada, Spain, Italy, France, Germany, World, United Kingdom

» Read our Company Profiles

13 Companies

GlaxoSmithKline P.L.C.

United States

Management Strategies

United States

Abbott Laboratories

United States

Johnson and Johnson

United States

Medtronic Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.